Clinical Trials
13 trialsNCT07621406 2026-06-02
Efficacy and Safety of Sequential Autologous Hematopoietic Stem Cell Transplantation Combined With Tafasitamab, Lenalidomide, and Standard Immunochemotherapy for Relapsed/Refractory Diffuse Large B-cell Lymphoma
The First Affiliated Hospital of Soochow University
Phase 2 Active not recruiting
NCT05149755 2026-05-19
Evolutâ„¢ EXPAND TAVR II Pivotal Trial
Medtronic Cardiovascular
Phase NA Active not recruiting
NCT07301424 2026-05-06
Subcutaneous Blinatumomab Plus Ponatinib for BCR-ABL+ B-ALL
University of Alberta
Phase 2 Not yet recruiting
NCT05509751 2026-04-28
SOAR
University of Toronto
Phase NA Active not recruiting
NCT07526597 2026-04-13
STOP-CLL-DCT
UNC Lineberger Comprehensive Cancer Center
Phase 2 Not yet recruiting
NCT07463781 2026-03-13
NEURO_CAR-T
Fondazione Italiana Linfomi - ETS
Not yet recruiting
NCT01199562 2026-01-28
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant
City of Hope Medical Center
Active not recruiting
NCT07371533 2026-01-28
A-319
Shanxi Bethune Hospital
Phase NA Not yet recruiting
NCT07077512 2026-01-21
Relmacabtagene Autoleucel Combined With Sintilimab for Relapsed/Refractory B-cell Lymphoma
Sun Yat-sen University
Phase 2 Recruiting
NCT04545762 2026-01-14
Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma
University of California, San Francisco
Phase 1 Recruiting
NCT04345718 2025-12-09
EXHITENTRE
Hennepin Healthcare Research Institute
Phase 2/3 Completed
NCT05655546 2025-08-08
ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals
Scripps Translational Science Institute
Phase NA Terminated
NCT05444348 2025-07-29
ACT
Rigshospitalet, Denmark
Phase NA Recruiting